Coronavirus Research

When the message matters, use science to craft it

An interdisciplinary initiative called the Message Effects Lab aims to understand, tap into, and develop communication around what motivates specific behaviors for specific populations. Its first projects center around COVID-19 testing and vaccines.

Michele W. Berger

An ‘electronic nose’ to sniff out COVID-19

Through a newly funded grant, researchers across the University are developing a device that can rapidly detect COVID-19 based on the disease’s unique odor profile.

Erica K. Brockmeier



In the News


CBS News

The mRNA miracle workers

Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.

FULL STORY →



Minnesota Public Radio

Review of COVID death stats finds likely undercount in official numbers

A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.

FULL STORY →



Philadelphia Inquirer

The Franklin Institute honors nine scientists and engineers on its 200th anniversary

Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.

FULL STORY →



Boston Globe

You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why

Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.

FULL STORY →



NPR

Long COVID brain fog may originate in a surprising place, say scientists

A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.

FULL STORY →



Time

Long COVID research is in its ‘most hopeful’ phase yet

A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.

FULL STORY →